• Login
Tuesday, June 9, 2026
Geneva Times
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil
No Result
View All Result
Geneva Times
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
Home Business

GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover

GenevaTimes by GenevaTimes
June 9, 2026
in Business
Reading Time: 1 min read
0
GSK boosts cancer portfolio with .6 billion Nuvalent takeover
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter



GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover
GSK boosts cancer portfolio with $10.6 billion Nuvalent takeover

Read More

Previous Post

Israeli air strikes hit Lebanese city of Tyre despite Iranian warning to stop attacks

 Next Post

Commission imposes interim measures on Meta to preserve free access to WhatsApp for rival AI assistants
Next Post

Commission imposes interim measures on Meta to preserve free access to WhatsApp for rival AI assistants

ADVERTISEMENT
Facebook Twitter Instagram Youtube LinkedIn

Explore the Geneva Times

  • About us
  • Contact us

Contact us:

editor@thegenevatimes.ch

Visit us

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Editorial
  • Switzerland
  • Europe
  • International
  • UN
  • Business
  • Sports
  • More
    • Article
    • Tamil

© 2023 -2024 Geneva Times| Desgined & Developed by Immanuel Kolwin